A detailed history of Creative Planning transactions in Galapagos Nv stock. As of the latest transaction made, Creative Planning holds 21,870 shares of GLPG stock, worth $629,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,870
Previous 18,407 18.81%
Holding current value
$629,637
Previous $456,000 37.94%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$24.2 - $30.67 $83,804 - $106,210
3,463 Added 18.81%
21,870 $629,000
Q2 2024

Aug 15, 2024

BUY
$24.78 - $32.48 $456,125 - $597,859
18,407 New
18,407 $456,000
Q1 2021

Apr 30, 2021

SELL
$76.15 - $111.94 $287,161 - $422,125
-3,771 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$96.85 - $148.25 $365,221 - $559,050
3,771 New
3,771 $373,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.